COVID-19 and Alzheimer’s Disease
COVID-19 и болезнь Альцгеймера
2021-02-27
SCID: 54.1/6h5etxcw
Discuss with AI
Alzheimer’s diseaseCOVID-19SARS-CoV-2neuroinvasive potentialneurological biomarkers
Figures from the paper
Abstract (AI)
The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is a neurotropic virus with a high neuroinvasive potential. Indeed, more than one-third of patients develop neurological symptoms, including confusion, headache, and hypogeusia/ageusia. However, long-term neurological consequences have received little interest compared to respiratory, cardiovascular, and renal manifestations. Several mechanisms have been proposed to explain the potential SARS-CoV-2 neurological injury that could lead to the development of neurodegenerative diseases, including Alzheimer's Disease (AD). A mutualistic relationship between AD and COVID-19 seems to exist. On the one hand, COVID-19 patients seem to be more prone to developing AD. On the other hand, AD patients could be more susceptible to severe COVID-19. In this review, we sought to provide an overview on the relationship between AD and COVID-19, focusing on the potential role of biomarkers, which could represent precious tool for early identification of COVID-19 patients at high risk of developing AD.
Key Findings
1
Biomarkers may help identify COVID-19 patients at high risk of subsequently developing Alzheimer’s disease.
2
Proposed mechanisms of SARS-CoV-2-related neurological injury may contribute to the later development of neurodegenerative diseases, including Alzheimer’s disease.
3
SARS-CoV-2 has substantial neuroinvasive potential, with more than one-third of patients developing neurological symptoms such as confusion, headache, or taste loss.
4
The long-term neurological consequences of COVID-19 remain comparatively understudied relative to its respiratory, cardiovascular, and renal effects.
5
The relationship between COVID-19 and Alzheimer’s disease may be bidirectional: COVID-19 could increase Alzheimer’s disease risk, while Alzheimer’s disease could increase susceptibility to severe COVID-19.
Research Object
the relationship between Alzheimer’s disease and COVID-19
Research Subject
the bidirectional susceptibility and potential biomarker-mediated mechanisms linking COVID-19 with Alzheimer’s disease, including the risk of post-COVID-19 AD development and severe COVID-19 in AD patients
Publication Details
Publication Date
2021-02-27
Journal
Publisher
ISSN
Cited by
118
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest
References available in scid.ai3
Postmortem examination of COVID‐19 patients reveals diffuse alveolar damage with severe capillary congestion and variegated findings in lungs and other organs suggesting vascular dysfunction2020
Neuropathology of COVID-19: a spectrum of vascular and acute disseminated encephalomyelitis (ADEM)-like pathology2020
Neuroinfection may contribute to pathophysiology and clinical manifestations of COVID‐192020